MedTrace Logo

The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System

NCT06990048 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-05-12

No results posted yet for this study

Summary

This is an observational, retrospective, multicenter study to evaluate the performance of the AFX2 System using real world evidence from VQI-VISION.

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

AFX2 System

The AFX2 System comprises of the following: AFX2 Bifurcated Endograft System and delivery system AFX Vela Proxmal Endograft System and delivery system AFX Stand Alone Endograft System and delivery system

Sponsors & Collaborators

  • Fivos

    collaborator UNKNOWN

  • Endologix

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-21
Primary Completion
2027-05-31
Completion
2027-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06990048 on ClinicalTrials.gov